Director of Health Grant Colfax and Jonathan Sears, director of the vaccine branch, told the San Francisco Health Commission that the city is prepared to offer COVID‑19 vaccines to children ages 5–11 as soon as state guidance follows the CDC’s recommendations. Sears said the department estimates about 45,000 children in that age group live in San Francisco and described a three‑pronged delivery approach: school‑based sites, health‑system partners (Kaiser, UCSF, Sutter, Dignity) and community/pharmacy access points.
"Today is a very significant day in this timeline," Sears said, describing steps the city has taken to ensure low‑barrier access, on‑site pediatric expertise through an "Ask the Expert" program, and targeted school events meant to make vaccination comfortable for families. Colfax highlighted multilingual town halls scheduled in the days after the meeting and said more than 1,000 people had already signed up for the initial event.
The presentation included data on local trends: Colfax reported San Francisco’s case rate at about six per 100,000 residents and noted hospitalizations were steady in the 40–45 range. He said 76% of residents are fully vaccinated and 84% of eligible residents have completed the series. Officials emphasized vaccines’ role in preventing hospitalizations and deaths and said they will monitor uptake by using the California Immunization Registry (CARE) to identify gaps and target outreach.
Sears reviewed booster guidance released through the federal process and summarized local planning: mRNA recipients are eligible for boosters six months after their second dose, with specific priority groups (older adults, people with underlying medical conditions, residents of long‑term care), and Johnson & Johnson recipients are eligible two months after their single dose. He said the city is working with CDPH and Western States review groups to finalize local operational guidance.
Commissioners asked when the department would have reliable uptake figures for 5–11 year olds, how many school sites would offer vaccine and whether school‑based access would reflect broader community uptake. Sears said four school‑based sites had been launched with SFUSD and that vaccine data will be tracked through CARE; he committed to returning more detailed breakdowns on school populations and uptake when available. Colfax and Sears said they will monitor booster and pediatric uptake and adjust outreach — including targeted efforts for older adults and linguistically diverse communities — based on those data.
The commission did not take action on the presentation; the next procedural step for pediatric vaccination is receipt of state guidance and vaccine supply, after which DPH will move to operational rollout at the described sites.